Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rajaraman

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Allergy|July 1, 1978
Cellular immunity to a lung homogenate in asymptomatic cigarette smokersJ R Dill, R A Fox, P L Landrigan, et al.
CNS Drugs|July 26, 2024
Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International DatabaseKingsley Wong, Mohammed Junaid, Solomon Alexander, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 4, 2024
Computational EEG attributes predict response to therapy for epileptic spasmsRajsekar R Rajaraman, Rachel J Smith, Shingo Oana, et al.
Epilepsy Research|November 25, 2021
Automated preprocessing and phase-amplitude coupling analysis of scalp EEG discriminates infantile spasms from controls during wakefulnessMakoto Miyakoshi, Hiroki Nariai, Rajsekar R Rajaraman, et al.
Epilepsia|June 7, 2024
Bilateral centromedian nucleus of thalamus responsive neurostimulation for pediatric-onset drug-resistant epilepsySamuel Ahn, Benjamin Edmonds, Rajsekar R Rajaraman, et al.
Hybridoma|April 1, 1990
Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patientA K Guha, T Ghose, S J Luner, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Journal of Child Neurology|July 8, 2025
Electroencephalogram (EEG) Spike Metrics Discriminate Impending Epileptic Spasms From Other Seizures in Children With Tuberous Sclerosis Complex: A Pilot StudyPauline J Brandon Bravo Bruinsma, Aristides Hadjinicolaou, Rajsekar R Rajaraman, et al.
Epilepsy Research|January 18, 2024
Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: A psychometric studyJ M Saldaris, P Jacoby, E D Marsh, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 3, 2024
Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trialJ Downs, P Jacoby, N Specchio, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Allergy|July 1, 1978
Cellular immunity to a lung homogenate in asymptomatic cigarette smokersJ R Dill, R A Fox, P L Landrigan, et al.
CNS Drugs|July 26, 2024
Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International DatabaseKingsley Wong, Mohammed Junaid, Solomon Alexander, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 4, 2024
Computational EEG attributes predict response to therapy for epileptic spasmsRajsekar R Rajaraman, Rachel J Smith, Shingo Oana, et al.
Epilepsy Research|November 25, 2021
Automated preprocessing and phase-amplitude coupling analysis of scalp EEG discriminates infantile spasms from controls during wakefulnessMakoto Miyakoshi, Hiroki Nariai, Rajsekar R Rajaraman, et al.
Epilepsia|June 7, 2024
Bilateral centromedian nucleus of thalamus responsive neurostimulation for pediatric-onset drug-resistant epilepsySamuel Ahn, Benjamin Edmonds, Rajsekar R Rajaraman, et al.
Hybridoma|April 1, 1990
Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patientA K Guha, T Ghose, S J Luner, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Journal of Child Neurology|July 8, 2025
Electroencephalogram (EEG) Spike Metrics Discriminate Impending Epileptic Spasms From Other Seizures in Children With Tuberous Sclerosis Complex: A Pilot StudyPauline J Brandon Bravo Bruinsma, Aristides Hadjinicolaou, Rajsekar R Rajaraman, et al.
Epilepsy Research|January 18, 2024
Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: A psychometric studyJ M Saldaris, P Jacoby, E D Marsh, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 3, 2024
Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trialJ Downs, P Jacoby, N Specchio, et al.
Pageof 7